[1] Holger T, Ibrahim A, Marcus S, et al. PCI strategies in patients with acute myocardial infarction and cardiogenic shock[J].N Engl J Med,2017,377(25):2419-2432. [2] 卢丽君,曹敏,沈艳,等.法舒地尔治疗慢性心力衰竭临床观察[J].中国医院药学杂志,2017,37(9):862-865. [3] 张春晓,陈玉东.左西孟旦与重组人脑利钠肽治疗AMI急诊PCI术后患者短期临床疗效的对比[J].临床心血管病杂志,2017,33(1):39-43. [4] 李伟,范卫泽,傅向华,等.RDW对急性ST段抬高型心肌梗死患者PCI术后心肌灌注水平及预后判断的价值[J].山东医药,2018,58(41):79-81. [5] Li XH, Wu X, Li HW,et al. Increased Rho kinase activity predicts worse cardiovascular outcome in ST-segment elevation myocardial infarction patients[J].Cardiol J,2016,23(4):456-464. [6] 李立卓,郑梅,李伟聪,等.法舒地尔联合不同剂量瑞舒伐他汀对冠状动脉慢血流的影响[J].中国全科医学,2019,22(34):4251-4255. [7] 罗静,向娟.重组人脑利钠肽对PCI术后患者心肌微循环及心肌酶谱的影响[J].中国急救复苏与灾害医学杂志,2020,15(4):406-409. [8] 李定良,李锋.PCI术前应用曲美他嗪对AMI患者术后氧化应激反应指标的影响[J].中国药房,2017,28(18):2489-2492. [9] Yu XM, He WB, Xie J,et al. Selective ablation of ligament of Marshall inhibits ventricular arrhythmias during acute myocardial infarction: Possible mechanisms[J].J Cardiovasc Electrophysiol,2019,30(3):374-382. [10] 吴从生. PCI围手术期柴胡注射液辅助治疗对心肌损害、氧化应激反应、细胞凋亡的影响[J].海南医学院学报,2018,24(10):994-997. |